RAC 3.77% $1.53 race oncology ltd

MST valuation of RAC, page-157

  1. 2,073 Posts.
    lightbulb Created with Sketch. 360
    Given we had a successful independent phase II for AML, as titans has indicated, the chances for a phase II based in US would be fairly low? And after that, theoretically we could progress for a buyout? So in binary terms we are pretty much 1 and not 0 for pillar III?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.